Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Net Income: $13,984M in FY2025, up 17.1% from a year earlier.
Latest, FY2025
13,984
Period ended Dec 31, 2025
Change on a year earlier
+17.1%
11,941 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Reported in Postgres DB + Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Income ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13,984 | +17.1% | Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 11,941 | -19.6% | Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗ |
| FY2023 | Dec 31, 2023 | 14,850 | +113.5% | Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗ |
| FY2022 | Dec 31, 2022 | 6,955 | -71.0% | Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 24,021 | +197.6% | Novartis 20-F (0001370368-22-000010, filed 2022-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 8,072 | -31.2% | Novartis 20-F (0001370368-21-000006, filed 2021-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 11,732 | -7.0% | Novartis 20-F (0001370368-20-000003, filed 2020-01-29) ↗ |
| FY2018 | Dec 31, 2018 | 12,611 | +63.7% | Novartis 20-F (0001370368-19-000002, filed 2019-01-30) ↗ |
| FY2017 | Dec 31, 2017 | 7,703 | +14.8% | Novartis 6-K (0001370368-18-000005, filed 2018-01-24) ↗ |
| FY2016 | Dec 31, 2016 | 6,712 | -62.3% | Novartis 6-K (0001370368-18-000005, filed 2018-01-24) ↗ |
| FY2015 | Dec 31, 2015 | 17,783 | – | Novartis 6-K (0001370368-18-000005, filed 2018-01-24) ↗ |
Cite this data
StockData. (2026). Novartis Net Income ($M), annual FY2015–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-net-inc-parent
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.